An addition of medium-dose ATG to conditioning regimens favours the long-term survival of patients w

• 作 者: Bingyi Wu Chaoyan Song Zhigang
• 机 构: DepartmentofHaematology
• 出 处: 干细胞探索(英文)
• 发表日期: 2013年1期
• 关键词: HEMATOPOIETIC Stem Cell Transplantation Long-Term Survival Anti-Human LYMPHOCYTE

Long-term survival of 116 leukemia/MDS patients received allo-SCT conditioned by a regimen with ATG-F or without ATG-F was analysed, together with the impact of ATG-F on the long-term survival, GVHD and disease relapse. Seventy patients received an ATG-F